Oncogenex Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Oncogenex Pharmaceuticals Inc
TickerACHV
CIK #0000949858
CUSIP004468203
SectorLife Sciences - In Vitro & In Vivo Diagnostic Substances
Address1522 217th Place SE, Bothell, WA 98021
Source [EDGAR]
CIK Filing 2011 - 2024
[0000949858] 10-K
[0000949858] 10-Q
[0000949858] 3
[0000949858] 4
[0000949858] 5
[0000949858] 8-K
[0000949858] D
[0000949858] SC 13D
[0000949858] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Dialectic Capital Management LP Achieve Life Sciences Inc [2023-04-18] 19.68
Dialectic Capital Management LP Achieve Life Sciences Inc [2023-01-20] 19.5
Contrarian Achieve SPV LP Achieve Life Sciences Inc [2022-11-28] 7.369
Dialectic Capital Management LP Achieve Life Sciences Inc [2022-11-21] 19.5
SVB Financial Group Achieve Life Sciences Inc [2021-12-29] 14.5
Francis Capital Management LLC Achieve Life Sciences Inc [2021-01-07] 5.0
Packer Paul Achieve Life Sciences Inc [2020-12-04] 5.8
Pura Vida Investments LLC Achieve Life Sciences Inc [2019-12-27] 7.79
CVI Investments Inc Achieve Life Sciences Inc [2019-12-26] 0.9
Adamas Health Care Fund Achieve Life Sciences Inc [2019-05-28] 5.37
UBS Group AG Achieve Life Sciences Inc [2019-02-14] 6.74
SIO Capital Management LLC Achieve Life Sciences Inc [2019-02-14] 8.89
Armistice Capital LLC Achieve Life Sciences Inc [2018-10-11] 7.6
Hirschman Orin Achieve Life Sciences Inc [2018-07-03] 7.3
Sabby Management LLC Achieve Life Sciences Inc [2018-06-19] 6.49
Schacter Robert Achieve Life Sciences Inc [2017-08-11] 0.0
Martell Ron Achieve Life Sciences Inc [2017-08-11] 0.0
Clarke Anthony Achieve Life Sciences Inc [2017-08-11] 6.6
Stewart Richard Alistair Achieve Life Sciences Inc [2017-08-11] 19.4
Biotechnology Value Fund L P Oncogenex Pharmaceuticals Inc [2014-12-12] 2.98
Sabby Management LLC Oncogenex Pharmaceuticals Inc [2014-11-07] 4.15
Great Point Partners LLC Oncogenex Pharmaceuticals Inc [2014-07-07] 0.99
FMR LLC Oncogenex Pharmaceuticals Inc [2012-04-10] 0.0
Tang Capital Partners LP Oncogenex Pharmaceuticals Inc [2012-03-22] 5.8
BlackRock Inc Oncogenex Pharmaceuticals Inc [2012-02-09] 5.78
Form 3/4/5 Filer 2011 - 2024
Martell Bridget A
Achieve Life Sciences Inc
Duty Stuart
Sellig Thomas
King Thomas Braxton
Himes Vaughn B
Bencich John
Stewart Richard Alistair
Jacobs Cindy
Wan Jerry
SVB Innovation Credit Partners VIII, LLC
SVB Innovation Credit Partners VIII-A, LLC
SVB Innovation Credit Fund VIII, L.P.
Innovation Credit Fund VIII-A, L.P.
SVB Financial Group
Dialectic Capital Management LP
Dialectic LS Manager LLC
Fichthorn John
Dialectic Life Sciences SPV LLC
Dialectic Partners, LLC
Joseph Donald
Moyes Jay M
Mattingly Martin A
Clarke Anthony
Cormack Scott Daniel
Parker H Stewart
Boyd Steven
Armistice Capital LLC
Armistice Capital Master Fund Ltd.
Schacter Robert
Smith David V
Goldstein Jack
Clendeninn Neil James
Wyrick Susan D.
Lawrence Cameron William
Griffin Michelle Renee
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com